---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-25-004918"
form_type: "8-K"
ticker: "EXPO"
cik: "0000851520"
company_name: "EXPONENT INC"
filed_at: "2025-07-31T23:59:59+00:00"
generated_at: "2026-05-17T22:37:00.943135+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Exponent Q2 EPS $0.52 vs $0.57 YoY; revenues flat, guides Q3 mid-single digit growth

## Summary
- Diluted EPS $0.52 (down from $0.57); net income $26.6M vs $29.2M in Q2 2024.
- Revenue before reimbursements flat at $132.9M; total revenue $142.0M (+1% YoY).
- EBITDA margin fell to 27.8% from 30.2%; environmental/health segment down 4%.
- Q3 guidance: rev before reimb up mid-single digits; EBITDA margin 26.75%-27.75%.
- Declares $0.30 quarterly dividend payable Sept 19, 2025; record Sept 5.

## SEC filing metadata
- accession: 0001171843-25-004918
- form_type: 8-K
- ticker: EXPO
- cik: 0000851520
- company_name: EXPONENT INC
- filed_at: 2025-07-31T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/851520/000117184325004918/0001171843-25-004918-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/851520/000117184325004918/f8k_073125.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-25-004918
- JSON: https://secwatch.observer/filing/0001171843-25-004918.json
- Plain text: https://secwatch.observer/filing/0001171843-25-004918.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
